Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 157,172 | 165,782 | 145,803 | 139,039 | 138,012 |
| Marketable Securities | 19,048 | N/A | N/A | N/A | N/A |
| Receivables | 113,731 | 109,455 | 94,954 | 79,991 | 74,476 |
| Inventories | 40,885 | 40,999 | 45,495 | 49,360 | 49,821 |
| Income taxes - deferred | 16,726 | 982 | 979 | 969 | 972 |
| TOTAL | $373,456 | $332,144 | $300,230 | $286,366 | $277,101 |
| Non-Current Assets | |||||
| PPE Net | 164,691 | 162,221 | 155,419 | 144,833 | 139,885 |
| Intangibles | 48,543 | 49,201 | 50,202 | 51,054 | 52,279 |
| Other Non-Current Assets | 199,711 | 8,440 | 9,134 | 9,389 | 8,286 |
| TOTAL | $412,945 | $219,862 | $214,755 | $205,276 | $200,450 |
| Total Assets | $786,401 | $552,006 | $514,985 | $491,642 | $477,551 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 20,000 | 44,000 | 2,500 | 2,500 |
| Accounts payable and accrued liabilities | 11,530 | 15,117 | 9,165 | 20,384 | 33,655 |
| Accrued Expenses | 66,915 | 68,400 | 55,392 | 44,407 | 46,200 |
| Other current liabilities | 4,743 | N/A | N/A | N/A | N/A |
| TOTAL | $85,262 | $107,945 | $112,198 | $70,084 | $84,418 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,652 | 3,283 | 2,710 | 1,898 | 1,128 |
| aiOther Non-Current Liabilities | 12,076 | 15,403 | 15,373 | 145,816 | 145,023 |
| TOTAL | $12,783 | $16,823 | $16,340 | $146,847 | $146,132 |
| Total Liabilities | $98,045 | $124,768 | $128,538 | $216,931 | $230,550 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 178,275 | 177,132 | 175,900 | 164,145 | 163,391 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -400,964 | -638,092 | -664,823 | -681,625 | -696,130 |
| Other shareholders' equity | -1,618 | -10,313 | -5,084 | 3,105 | 2,687 |
| TOTAL | $688,356 | $427,238 | $386,447 | $274,711 | $247,001 |
| Total Liabilities And Equity | $786,401 | $552,006 | $514,985 | $491,642 | $477,551 |